` Comparison: TNGX, ABBV - Alpha Spread

TNGX
vs
ABBV

Over the past 12 months, TNGX has underperformed ABBV, delivering a return of -39% compared to the ABBV's +9% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
TNGX
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

TNGX Intrinsic Value
2.22 USD
Overvaluation 67%
Intrinsic Value
Price
ABBV Intrinsic Value
194.27 USD
Overvaluation 9%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Tango Therapeutics Inc
NASDAQ:TNGX
6.66 USD
Abbvie Inc
NYSE:ABBV
212.53 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
TNGX, ABBV

TNGX
ABBV
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Tango Therapeutics Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
TNGX, ABBV

TNGX
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Tango Therapeutics Inc
NASDAQ:TNGX
Abbvie Inc
NYSE:ABBV
What is Free Cash Flow?

Gross Margin

TNGX
0%
ABBV
70.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

Operating Margin

TNGX
-647.3%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

Net Margin

TNGX
-599.1%
ABBV
6.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

FCF Margin

TNGX
-615.8%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

ROE

TNGX
-76%
ABBV
112.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

ROA

TNGX
-47%
ABBV
2.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

ROIC

TNGX
-280.4%
ABBV
22.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

ROCE

TNGX
-58.8%
ABBV
18.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Tango Therapeutics Inc
Abbvie Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
TNGX, ABBV

Loading

Performance Gap
TNGX, ABBV

Loading
TNGX
ABBV
Difference
www.alphaspread.com

Performance By Year
TNGX, ABBV

Loading
TNGX
ABBV
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare TNGX to other stocks
Unlock Full Access to Alpha Spread
Create Free Account